Literature DB >> 12226536

Non-familial Alzheimer's disease is mainly due to genetic factors.

J Wesson Ashford1, James A Mortimer.   

Abstract

This team takes the position that what is commonly referred to as non-familial Alzheimer's disease (AD) is predominantly due to genetic factors. Population-based studies suggest that genetic factors cause the majority of cases that begin after age 60. There are several lines of evidence supporting this position: Data from the Nun Study suggest that the risk for AD is largely established by early adulthood, implying that later adult exposures likely play only a small role in causation. Family studies show that first-degree blood relatives of persons with non-familial AD have a substantially increased risk of AD relative to controls. Twin studies suggest that the heritability of AD exceeds 60%. Environmental factors, such as socioeconomic status, education, and head injury, are strong risk factors for AD only in individuals with a genetic predisposition. The APOE genotype is a powerful risk factor for AD and accounts for as much as 50%. There are numerous other candidate genes with strong associations with AD that presumably explain the remaining population risk. This paper further reviews the mechanisms associated with AD causation for APOE and other candidate genes and implications for the development of prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226536     DOI: 10.3233/jad-2002-4307

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  55 in total

1.  Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.

Authors:  Andrew J Saykin; Li Shen; Tatiana M Foroud; Steven G Potkin; Shanker Swaminathan; Sungeun Kim; Shannon L Risacher; Kwangsik Nho; Matthew J Huentelman; David W Craig; Paul M Thompson; Jason L Stein; Jason H Moore; Lindsay A Farrer; Robert C Green; Lars Bertram; Clifford R Jack; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Authors:  Jason J Corneveaux; Amanda J Myers; April N Allen; Jeremy J Pruzin; Manuel Ramirez; Anzhelika Engel; Michael A Nalls; Kewei Chen; Wendy Lee; Kendria Chewning; Stephen E Villa; Hunsar B Meechoovet; Jill D Gerber; Danielle Frost; Hollie L Benson; Sean O'Reilly; Lori B Chibnik; Joshua M Shulman; Andrew B Singleton; David W Craig; Kendall R Van Keuren-Jensen; Travis Dunckley; David A Bennett; Philip L De Jager; Christopher Heward; John Hardy; Eric M Reiman; Matthew J Huentelman
Journal:  Hum Mol Genet       Date:  2010-06-09       Impact factor: 6.150

Review 3.  The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Enchi Liu; John C Morris; Ronald C Petersen; Andrew J Saykin; Mark E Schmidt; Leslie Shaw; Judith A Siuciak; Holly Soares; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

4.  Increased functional brain response during word retrieval in cognitively intact older adults at genetic risk for Alzheimer's disease.

Authors:  Christina E Wierenga; Nikki H Stricker; Ashley McCauley; Alan Simmons; Amy J Jak; Yu-Ling Chang; Lisa Delano-Wood; Katherine J Bangen; David P Salmon; Mark W Bondi
Journal:  Neuroimage       Date:  2010-03-16       Impact factor: 6.556

5.  SORL1 Is Associated with the Risk of Late-Onset Alzheimer's Disease: a Replication Study and Meta-Analyses.

Authors:  Cheng-Cheng Zhang; Hui-Fu Wang; Meng-Shan Tan; Yu Wan; Wei Zhang; Zhan-Jie Zheng; Ling-Li Kong; Zi-Xuan Wang; Lin Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-02-13       Impact factor: 5.590

Review 6.  Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression.

Authors:  James A Mortimer; Amy R Borenstein; Karen M Gosche; David A Snowdon
Journal:  J Geriatr Psychiatry Neurol       Date:  2005-12       Impact factor: 2.680

7.  Accounting for the relationship between low education and dementia: a twin study.

Authors:  Margaret Gatz; James A Mortimer; Laura Fratiglioni; Boo Johansson; Stig Berg; Ross Andel; Michael Crowe; Amy Fiske; Chandra A Reynolds; Nancy L Pedersen
Journal:  Physiol Behav       Date:  2007-05-21

8.  Alzheimer's disease beyond APOE.

Authors:  Michael A van Es; Leonard H van den Berg
Journal:  Nat Genet       Date:  2009-10       Impact factor: 38.330

Review 9.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

10.  Using genetics to enable studies on the prevention of Alzheimer's disease.

Authors:  D G Crenshaw; W K Gottschalk; M W Lutz; I Grossman; A M Saunders; J R Burke; K A Welsh-Bohmer; S K Brannan; D K Burns; A D Roses
Journal:  Clin Pharmacol Ther       Date:  2012-11-07       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.